|
🐜
|
Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial
47 auth.
C. Parsons,
N. Harvey,
L. Shepstone,
J. Kanis,
E. Lenaghan,
S. Clarke,
R. Fordham,
N. Gittoes,
I. Harvey,
R. Holland,
N. Redmond,
A. Howe,
T. Marshall,
T. Peters,
D. Torgerson,
...
T. O’Neill,
E. McCloskey,
C. Cooper,
N. H. J. F. K. K. C. E. C. H. D. V. J. T. S. M. K. C. Crabtree Duffy Parle Rashid Stant Taylor Thomas Kn,
N. Crabtree,
H. Duffy,
J. Parle,
F. Rashid,
K. Stant,
K. Taylor,
C. Thomas,
E. Knox,
C. Tenneson,
H. Williams,
D. Adams,
V. Bion,
J. Blacklock,
T. Dyer,
S. Bratherton,
M. Fidler,
K. Knight,
C. Mcgurk,
K. Smith,
S. Young,
K. Collins,
J. Cushnaghan,
C. Arundel,
K. Bell,
L. Clark,
S. Collins,
S. Gardner,
N. Mitchell
|
4 |
2019 |
4
🐜
|
|
🐜
|
Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study
50 auth.
E. Söreskog,
F. Borgström,
L. Shepstone,
S. Clarke,
C. Cooper,
I. Harvey,
N. Harvey,
A. Howe,
H. Johansson,
T. Marshall,
T. O’Neill,
T. Peters,
N. Redmond,
D. Turner,
R. Holland,
...
E. McCloskey,
J. Kanis,
A. Heawood,
N. Crabtree,
H. Duffy,
N. Gittoes,
J. Parle,
F. Rashid,
K. Stant,
K. Taylor,
C. Thomas,
E. Knox,
C. Tenneson,
H. Williams,
D. Adams,
V. Bion,
J. Blacklock,
T. Dyer,
R. Fong-Soe-Khioe,
E. Lenaghan,
S. Bratherton,
M. Fidler,
K. Knight,
C. Mcgurk,
K. Smith,
S. Young,
K. Collins,
J. Cushnaghan,
C. Arundel,
K. Bell,
L. Clark,
S. Collins,
S. Gardner,
N. Mitchell,
D. Torgeson
|
4 |
2020 |
4
🐜
|
|
🐢
|
Analysis of Genetic Host Response Risk Factors in Severe COVID-19 Patients
10 auth.
K. Taylor,
S. Das,
M. Pearson,
J. Kozubek,
M. Pawłowski,
C. Jensen,
...
Z. Skowron,
G. Møller,
M. Strivens,
S. Gardner
|
4 |
2020 |
4
🐢
|
|
🐜
|
Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study
53 auth.
C. Condurache,
S. Chiu,
P. Chotiyarnwong,
H. Johansson,
L. Shepstone,
E. Lenaghan,
C. Cooper,
S. Clarke,
R. F. S. Khioe,
R. Fordham,
N. Gittoes,
I. Harvey,
N. Harvey,
A. Heawood,
R. Holland,
...
A. Howe,
J. Kanis,
T. Marshall,
T. O’Neill,
T. Peters,
N. Redmond,
D. Torgerson,
D. Turner,
E. McCloskey,
N. H. J. F. K. K. C. E. C. H. D. V. J. T. S. M. K. C. Crabtree Duffy Parle Rashid Stant Taylor Thomas Kn,
N. Crabtree,
H. Duffy,
J. Parle,
F. Rashid,
K. Stant,
K. Taylor,
C. Thomas,
E. Knox,
C. Tenneson,
H. Williams,
D. Adams,
V. Bion,
J. Blacklock,
T. Dyer,
S. Bratherton,
M. Fidler,
K. Knight,
C. Mcgurk,
K. Smith,
S. Young,
K. Collins,
J. Cushnaghan,
C. Arundel,
K. Bell,
L. Clark,
S. Collins,
S. Gardner,
N. Mitchell
|
2 |
2020 |
2
🐜
|
|
🐢
|
Identification and Analysis of Shared Risk Factors in Sepsis and High Mortality Risk COVID-19 Patients
10 auth.
S. Das,
K. Taylor,
M. Pearson,
J. Kozubek,
M. Pawłowski,
C. Jensen,
...
Z. Skowron,
G. Møller,
M. Strivens,
S. Gardner
|
1 |
2020 |
1
🐢
|
|
🐬
|
Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis.
C. Wei,
S. Gardner,
A. Rachlis,
L. L. Pack,
C. Chan
|
1 |
2001 |
1
🐬
|
